	A Mendelian randomization study investigating the causal associations of 35 blood and urinary metabolite biomarkers with breast cancer development. Discov Oncol Lin T, Liu Y, Liu Z, Liu A, Liu R, Wang Q. PMID: 40316766 [PubMed]
	Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional study. BMJ Open Omeranovic A, Lapointe J, Fortier P, Bergeron AS, Dorval M, Chiquette J, Boubaker A, Eloy L, Turgeon A, Lambert-Côté L, Joly Y, Brooks JD, Walker MJ, Stockley T, Pashayan N, Antoniou A, Easton D, Chiarelli AM, Knoppers B, Simard J, Nabi H. PMID: 40316347 [PubMed - in process]
	Angiogenesis and immune microenvironment in triple-negative breast cancer: Targeted therapy. Biochim Biophys Acta Mol Basis Dis Zhang Y, Yang H, Jiang Y, Jiang Y, Mao R. PMID: 40316057 [PubMed - as supplied by publisher]
	Body Mass Index and Clinical Outcomes in Breast Cancer Patients Undergoing Endocrine Therapy: A Meta-Analysis and Mendelian Randomization Study. Clin Nutr ESPEN Lin X, Sun H, Wei X, Xie M, Chen L, Hu CT, Cai J. PMID: 40315988 [PubMed - as supplied by publisher]
	A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study. JMIR Cancer Huebner H, Wurmthaler LA, Goossens C, Ernst M, Mocker A, Krückel A, Kallert M, Geck J, Limpert M, Seitz K, Ruebner M, Kreis P, Heindl F, Hörner M, Volz B, Roth E, Hack CC, Beckmann MW, Uhrig S, Fasching PA. PMID: 40315425 [PubMed - in process]
	Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene? Am Soc Clin Oncol Educ Book Lee KL, Eniu A, Booth CM, MacDonald M, Chino F. PMID: 40315376 [PubMed - in process]
	Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviour. PLoS One Douglas CM, Newell M, Goruk S, Courneya KS, Ghosh S, Joy AA, Munhoz J, Field CJ. PMID: 40315249 [PubMed - indexed for MEDLINE]
	Metabolomics as a tool for understanding and treating triple-negative breast cancer. Naunyn Schmiedebergs Arch Pharmacol Khan G, Hussain MS, Ahmad S, Alam N, Ali MS, Alam P. PMID: 40314763 [PubMed - as supplied by publisher]
	Developmental Regulation of circRNAs in Normal and Diseased Mammary Gland: A Focus on circRNA-miRNA Networks. J Mammary Gland Biol Neoplasia Marei S, Maatouk N, AbouHaidar M, Talhouk R. PMID: 40314719 [PubMed - indexed for MEDLINE]
	Feasibility of virtual T2-weighted fat-saturated breast MRI images by convolutional neural networks. Eur Radiol Exp Liebert A, Hadler D, Ehring C, Schreiter H, Brock L, Kapsner LA, Eberle J, Erber R, Emons J, Laun FB, Uder M, Wenkel E, Ohlmeyer S, Bickelhaupt S. PMID: 40314707 [PubMed - indexed for MEDLINE]
	NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys Poppe MM, Boucher K, Gaffney DK, Brownson KE, Smith G, Howell JN, Ticona FF, Kim J, Burt L, Cannon D, Kokeny K. PMID: 40314623 [PubMed - as supplied by publisher]
	Evaluating Automated Tools for Lesion Detection on (18)F Fluoroestradiol PET/CT Images and Assessment of Concordance with Standard-of-Care Imaging in Metastatic Breast Cancer. Radiol Imaging Cancer Miller R, Battle M, Wangerin K, Huff DT, Weisman AJ, Chen S, Perk TG, Ulaner GA. PMID: 40314583 [PubMed - indexed for MEDLINE]
	Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study. J Am Heart Assoc Yadalam AK, Liu C, Sun YV, Mandawat A, Quyyumi AA, Hayek SS. PMID: 40314383 [PubMed - as supplied by publisher]
	Efficacy of Modified Triple Assessment in Diagnosing Breast Lesions: A Prospective Observational Study. Cureus More RS, Dumbre S, Dikle AM. PMID: 40314043 [PubMed]
	Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery. Front Immunol Kang Z, Wang J, Liu J, Du L, Liu X. PMID: 40313963 [PubMed - indexed for MEDLINE]
	Pretreatment Axillary Nodal Volume as a Prognostic Factor for Breast Cancer. Breast J Jeong Y, Kim JH, Kim SS, Jung J, Joo JH, Kim HJ, Kim HH, Cha JH, Shin HJ, Ahn SD. PMID: 40313914 [PubMed - indexed for MEDLINE]
	Cardiovascular disease in breast cancer patients: a nationwide real-world evidence study 2013-20. Eur Heart J Open Engebretsen I, Oteiza F, Birkelund EF, Brandal SM, Bugge C, Halvorsen S. PMID: 40313733 [PubMed]
	DEEP LEARNING FOR AUTOMATED DETECTION OF BREAST CANCER IN DEEP ULTRAVIOLET FLUORESCENCE IMAGES WITH DIFFUSION PROBABILISTIC MODEL. Proc IEEE Int Symp Biomed Imaging Ghahfarokhi SS, To T, Jorns J, Yen T, Yu B, Ye DH. PMID: 40313564 [PubMed]
	Construction of a novel five programmed cell death-related gene signature as a promising prognostic model for triple negative breast cancer. PeerJ Shao Q, Gao HY, Wang ZY, Qian YL, Chen WX. PMID: 40313394 [PubMed - indexed for MEDLINE]
	Workload reduction of digital breast tomosynthesis screening using artificial intelligence and synthetic mammography: a simulation study. J Med Imaging (Bellingham) Dahlblom V, Dustler M, Zackrisson S, Tingberg A. PMID: 40313361 [PubMed]

Articles 1 - 20 / 203591

Page 1 of 10180



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy